Geode Capital Management
DRUG

Geode Capital Management’s Bright Minds Biosciences DRUG Stock Holding History

Geode Capital Management’s Portfolio DRUG Stock Details DRUG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.47M Buy
88,716
+25,170
+40% +$2.03M ﹤0.01% 2616
2025
Q4 		$4.96M Buy
63,546
+5,647
+10% +$377K ﹤0.01% 2777
2025
Q3 		$3.51M Buy
57,899
+378
+0.7% +$14.7K ﹤0.01% 2953
2025
Q2 		$1.5M Buy
+57,521
New +$1.72M ﹤0.01% 3213

Other funds holding DRUG

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Geode Capital Management's DRUG Position: Q1 2026 in Review

Geode Capital Management increased its Bright Minds Biosciences (DRUG) stake by 40% in Q1 2026, buying an estimated $2.03M and bringing the position to 88,716 shares worth $6.47M. The position accounts for ﹤0.01% of the portfolio, ranked #2616.

Geode Capital Management first reported a position in DRUG in Q2 2025 and has held it in 4 quarters since. 94 funds tracked by Wall St. Rank hold DRUG as of Q1 2026.

  • Geode Capital Management held 88,716 shares of Bright Minds Biosciences worth $6.47M as of Q1 2026.
  • Geode Capital Management bought 25,170 Bright Minds Biosciences shares in Q1 2026, an estimated $2.03M.
  • Bright Minds Biosciences made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #2616 holding.
  • Geode Capital Management first reported a position in Bright Minds Biosciences in Q2 2025 and has held it in 4 quarters since.
  • 94 funds tracked by Wall St. Rank held Bright Minds Biosciences as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.